VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced the appointment of Timothy P. Walbert, chairman, president and chief executive officer (CEO) of Horizon Therapeutics plc, to the Company’s Board of Directors. “We are fortunate to have Tim join us at this critical juncture as we adv
Full ArticleAurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors
Business Wire
0 shares
1 views